Abstract
The diagnosis of endometriosis has historically been hampered by an average diagnostic delay of seven to ten
years, owing largely to the field’s reliance on invasive surgical laparoscopy as the “gold standard.” The integra -
tion of artificial intelligence (AI) and machine learning (ML) into clinical pathology, however, is now catalyzing a
paradigm shift toward non-invasive, precision diagnostics. This report synthesizes research published between
2020 and 2026, highlighting the emergence of high-accuracy diagnostic tools built on microRNA (miRNA) sig -
natures, plasma protein panels, and genomic markers. Key findings include the validation of blood- and sali -
va-based miRNA signatures achieving area under the curve (AUC) values exceeding 0.95, rivaling the accuracy of
surgical diagnosis. AI methodologies including Random Forest, eXtreme Gradient Boosting (XGBoost), and sup-
port vector machines (SVM) have identified novel biomarkers such as PNMA2, LRP1, and WISP2/CCN5. These
advances promise not only to shorten diagnostic latency but also to enable molecular stratification, supporting
more personalized treatment strategies. Challenges remain in clinical standardization and in validating certain
protein-based models, yet the accumulated evidence suggests that AI-driven clinical pathology will soon aug -
ment and in some cases replace traditional surgical diagnosis for many patients.
Abbreviations: AI: Artificial Intelligence; ML: Machine Learning; miRNA: microRNA; AUC: Area Under the
Curve; SVM: Support Vector Machines; ANN: Artificial Neural Networks; CNN: Convolutional Neural Networks;
WGCNA: Weighted Gene Co-Expression Network Analysis
ARTICLE INFO
Received:
August 07, 2026
Published:
August 19, 2026
Citation: Raouf Roshdy and Reham
A Rashed. The Role of Artificial Intel -
ligence in Revolutionizing Endome -
triosis Diagnosis and Clinical Pathol -
ogy: A Commentary Review of New
Biomarkers (2020–2026) . Biomed
J Sci & Tech Res 66(3)-2026. BJSTR.
MS.ID.010350.
Introduction
Endometriosis is a complex, multifactorial inflammatory disease
characterized by the presence of endometrial-like tissue outside the
uterine cavity. It affects millions of individuals worldwide and is a
leading cause of chronic pelvic pain and infertility [1]. Despite this
prevalence, the current diagnostic framework remains significantly
flawed: laparoscopy an invasive surgical procedure carrying real risks
and high costs remains the only definitive diagnostic method [2,3].
This reliance on surgery contributes to substantial diagnostic delays
and prolonged patient suffering. Clinical pathology is now undergo -
ing a transformation driven by artificial intelligence. By leveraging
large multi-omics datasets (transcriptomics, proteomics, methylom -
ics) alongside high-resolution imaging, AI-based tools are uncovering
patterns “crimson clues,” in the words of one recent review within
peripheral blood, saliva, and tissue that are invisible to the human eye
[4,5]. These technologies aim to shift endometriosis diagnosis away
from a purely symptom-based or surgical approach and toward one
grounded in precision medicine and molecular stratification [3,5].
This report examines the AI methodologies, novel biomarkers, and
clinical impacts described in the recent literature, with the goal of
providing a comprehensive overview of the current state of the art.
AI Methodologies and Approaches in the Sources
The literature reviewed here reveals a diverse array of AI and
machine learning methodologies, each tailored to a particular type
of biological data. Broadly, these approaches fall into two categories:
supervised learning for classification, and unsupervised learning for
subtype identification.
Copyright@ : Raouf Roshdy | Biomed J Sci & Tech Res | BJSTR.MS.ID.010350.
Volume 66- Issue 3
DOI: 10.26717/BJSTR.2026.66.010350
58791
Supervised Learning and Ensemble Methods
The most common application of AI in the sources reviewed is
supervised learning used to differentiate patients with endometriosis
from healthy controls.
• Ensemble classifiers : “GenomeForest” is an advanced en -
semble machine learning classifier that uses chromosomal
partitioning to analyze transcriptomic and methylomic data,
achieving F1 scores as high as 0.968 [6].
• Tree-based models : Random Forest, XGBoost, and Ada -
Boost are frequently favored for their robustness in handling
high-dimensional omics data. Random Forest algorithms, for
example, have been used to validate salivary miRNA signa -
tures with 96.2% sensitivity [7] and to identify driver bio -
markers from RNA-seq data [8].
• Neural networks: Artificial neural networks (ANN) and con -
volutional neural networks (CNN) are increasingly applied to
complex diagnostic models and imaging data [8,9].
Integrated Discovery Pipelines
Many studies rely on hybrid pipelines that combine bioinformat -
ics with machine learning for biomarker screening.
• WGCNA and ML: Weighted gene co-expression network anal-
ysis (WGCNA) is often paired with machine learning to iden -
tify lipid metabolism-related biomarkers and molecular sub -
types [10].
• Multi-omics integration: Markov et al. describe the integra -
tion of ML and deep learning with imaging, molecular bio -
markers, and histopathology to build multi-omics diagnostic
pathways [11].
• Stacked models: Stacked machine learning models have been
developed to distinguish endometriosis from adenomyosis us-
ing peripheral blood and coagulation data [12].
Findings and Comparative Analysis
The synthesis of recent research points to several high-potential
biomarker categories, with miRNA signatures currently showing the
greatest diagnostic accuracy.
miRNA Signatures and Non-Invasive Diagnostics
MicroRNAs have emerged as the most promising candidates for
non-invasive testing.
• Blood-based signatures: Bendifallah et al. [13] developed an
86-miRNA signature using algorithms such as Random Forest
and XGBoost, achieving an AUC of 0.984 [13] a robust, repro -
ducible diagnostic that could potentially replace laparoscopy
[13].
• Saliva-based testing: A 109-miRNA saliva signature has been
validated with 96.2% sensitivity and 95.1% specificity [7].
This approach offers a genuinely non-invasive alternative that
could be administered in a primary care setting, meaningfully
shortening the path to diagnosis [14].
• Early-stage detection : Specific miRNA panels (e.g., miR-
199a, miR-122) combined with CA-125 have demonstrated an
AUC of 0.939 for detecting early-stage disease [15].
Proteomic and Immunologic Biomarkers
While miRNAs dominate the literature, protein- and im -
mune-based markers offer critical insight into disease pathophysiol -
ogy.
• Plasma protein panels: Schoeman et al. [16] identified a pan-
el of 10 plasma protein biomarkers. Using a Random Forest
model, they achieved an AUC of 0.997 for severe endometrio-
sis, though accuracy for milder cases was considerably lower
(Model 2 AUC = 0.729) [16].
• Immune screening : Non-invasive immune screening tests
combined with ML (logistic regression) have identified mark-
ers predictive of disease, including IL-10 in Tc cells, reduced
NK cytotoxic activity, and CXCL1 [2].
• Challenges in reproducibility: Notably, Fishman [17] found
that some cytokine-based ML models performed no better
than chance, underscoring the need for rigorous standardiza-
tion in protein-based discovery [17].
Genomic and Transcriptomic Drivers
Machine learning has also proven instrumental in identifying the
molecular drivers underlying the disease.
• Hub genes : Integrated identification methods have pointed
to five key diagnostic genes FOS, EPHX1, DLGAP5, PCSK5, and
ADAT1 [18]. A separate study identified LRP1 as a potential
diagnostic and immunomodulatory target, showing a strong
correlation with M2 macrophage infiltration [19].
• Novel biomarkers : AI-driven screening has highlighted
PNMA2 (linked to malignant growth and anti-apoptosis) [20],
WISP2/CCN5 (a potential early-screening marker) [21], and
SPP1 (a modulator of macrophage polarization) [22].
• Cuproptosis-related genes : ML algorithms have identified
genes such as GLS and PDHA1 as being associated with endo -
metriosis progression and immune infiltration [23].
AI in Imaging and Digital Pathology
AI’s impact extends to the visual characterization of the disease
as well.
Copyright@ : Raouf Roshdy | Biomed J Sci & Tech Res | BJSTR.MS.ID.010350.
58792
Volume 66- Issue 3
DOI: 10.26717/BJSTR.2026.66.010350
• Automated recognition : Proof-of-concept studies have
demonstrated the automatic visual recognition of endometri-
osis lesions during laparoscopy using AI, a step that could help
standardize surgical assessment [24].
• Tissue segmentation: AI-based tissue segmentation and cell
identification in histological sections for instance, identifying
CD138+ cells are improving the precision of pathological diag-
nosis in infertility-associated conditions [25,26].
• Imaging integration: Deep learning models are increasing -
ly being integrated with ultrasound and MRI data to improve
detection of deep infiltrating endometriosis and ovarian endo-
metriomas [27,28].
Impact on Clinical Pathology and Diagnostic
Workflows
The integration of AI into clinical pathology is reshaping the diag-
nostic landscape in several ways:
• Reducing diagnostic latency : By enabling high-accuracy
blood or saliva tests, AI tools can identify candidate biomark -
er genes and signatures that shorten the years-long wait many
patients face for a diagnosis [6,21].
• Molecular stratification: AI enables identification of disease
subtypes, moving the field away from a one-size-fits-all ap -
proach and toward models informed by molecular, epidemio-
logic, and cell-specific data [5].
• Precision medicine : The development of diagnostic mod -
els that predict treatment response for example, PNMA2 as a
therapeutic target is helping guide more personalized thera -
peutic strategies [3,20].
• Augmenting the gold standard: While some sources suggest
AI could ultimately replace laparoscopy [13,15], others view
it instead as a powerful complement that improves the effi -
ciency and accuracy of existing histopathological and surgical
workflows [18,29,30].
References
1. A Ashish, K Kusum, S Rai, R Singh (2020) Endometriosis a brief review:
evaluation of crucial risk factors and current treatment regimes. Interna -
tional Journal of Advances in Medicine 7(12): 1896-1905.
2. N Attia, M Franzoi, M P McHale, A R Gargiulo, M S Abrão, et al. (2023) Iden-
tification of immunologic predictive biomarkers of endometriosis using a
non-invasive immune screening test in association with machine learning
modeling. Fertility and Sterility 120(4): e226-e227.
3. L N Onah, M N Ezenwaeze, C N Nwankwo (2026) Endometriosis: From
delayed diagnosis to precision medicine. International Journal of Science
and Research Archive 18(1): 306-314.
4. T Gibbons, N Rahmioglu, K T Zondervan, C M Becker (2024) Crimson
Copyright@ : Raouf Roshdy | Biomed J Sci & Tech Res | BJSTR.MS.ID.010350.
Volume 66- Issue 3
DOI: 10.26717/BJSTR.2026.66.010350
58793
clues: advancing endometriosis detection and management with novel
blood biomarkers. Fertility and Sterility 121(2): 145-163.
5. C R Nezhat, Tomiko T Oskotsky, Joshua F R, Susan J F, Angie T , et al. (2025)
Real World Perspectives on Endometriosis Disease Phenotyping Through
Surgery, Omics, Health Data, and Artificial Intelligence. npj Women’s
Health 3(1): 8.
6. S Akter, D Xu, S C Nagel, J J Bromfield, K E Pelch, et al. (2020) GenomeFor-
est: An Ensemble Machine Learning Classifier for Endometriosis, p. 33-42.
7. S Bendifallah, Y Dabi, S Suisse, L Delbos, A Spiers, et al. (2023) Validation
of a Salivary miRNA Signature of Endometriosis — Interim Data. NEJM
Evidence 2(7).
8. Zhen G, T Chu, J She, S Chen, P Wang, et al. (2026) Exploration of driver
biomarkers and immune microenvironment in patients with endometri -
osis: Evidence from RNA-seq and machine learning. Journal of Reproduc -
tive Immunology 175: 104872.
9. H Malvezzi, E B Marengo, S Podgaec, C de A Piccinato (2020) Endometri -
osis: current challenges in modeling a multifactorial disease of unknown
etiology. Journal of Translational Medicine 18(1): 1-21.
10. Y Guo, Y Hou, J Wu, N Lou, D Yang, et al. (2025) Identification and Subtype
Analysis of Lipid Metabolism-Related Diagnostic Biomarkers for Endo -
metriosis Based on WGCNA and Machine Learning. American Journal of
Reproductive Immunology, p. 94.
11. D Markov, J Gurung, U Khalid, K Bechev, V Aleksiev, et al. (2026) Emerging
Pathways to Non-Invasive Diagnosis in Endometriosis: Integrating Ma -
chine Learning, Deep Learning and Multi-Omics Biomarkers. Diagnostics
16(12): 1823.
12. W Wang, W Zeng, S Yang (2024) A stacked machine learning-based clas -
sification model for endometriosis and adenomyosis: a retrospective co -
hort study utilizing peripheral blood and coagulation markers. Frontiers
in Digital Health 6: 1463419.
13. S Bendifallah, Y Dabi, S Suisse, L Jornea, D Bouteiller, et al. (2022) MicroR-
Nome analysis generates a blood-based signature for endometriosis. Sci -
entific Reports 12(1).
14. Gaia-Oltean AI, Boitor D, Laura-Ancuta P , Geanina G, Teodora T , et al.
(2025) Non-Invasive Methods for Early Diagnosis of Endometriosis-A
Comprehensive Narrative Literature Review. Healthcare (Basel, Switzer -
land) 13(24): 3276.
15. M K Gałuszka, K K Figurny, P P Jagodziński, A Pławski (2025) Potential
biomarkers for early detection of endometriosis: current state of art (what
we know so far). Journal of Applied Genetics.
16. E M Schoeman, S Bringans, K Peters, T Casey, C Andronis, et al. (2024)
Identification of plasma protein biomarkers for endometriosis and the de-
velopment of statistical models for disease diagnosis. Human Reproduc -
tion 40(2): 270-279.
17. D Fishman (2022) Developing a data analysis pipeline for automated pro-
tein profiling in immunology.
18. H Zhang, H Zhang, H Yang, A N Shuid, D Sandai, et al. (2023) Machine
learning-based integrated identification of predictive combined diagnos -
tic biomarkers for endometriosis. Frontiers in Genetics 14: 1290036.
19. Xie Liu (2026) LRP1 as a potential diagnostic and immunomodulatory tar-
get in endometriosis: evidence from multi-omics and single-cell analyses.
Frontiers in Immunology p: 17.
20. Mengjun Zhang, Zidi Zhang, Jialin Wang, Haodi Yue, Xueling Lou, et al.
(2025) Unveiling the Role of PNMA2 in Endometriosis: From Proliferation
and Apoptosis to Immunomodulation. Journal of Cellular and Molecular
Medicine 29(9): e70576.
21. Sheng Dou, Shaohua Ling, Weihua Nong, Bixiao Wei, Yuehua Huang, et
al. (2025) WISP2/CCN5 revealed as a potential diagnostic biomarker for
endometriosis based on machine learning and single-cell transcriptomic
analysis. Functional & Integrative Genomics 25(1): 131.
22. Sijia Zhang, Yi Yang, Chen Zhang, Xiaoyao Che, Fawei Li, et al. (2025) SPP1
as a key modulator of M2 macrophage polarization promotes endometri -
osis progression via activation of the FAK/PI3K/AKT pathway: A bioinfor-
matics and experimental study. International Immunopharmacology 166:
115563.
23. Y Lu, J Wang, G Sun, Z Fang, Z Xing, et al. (2023) Machine learning algo -
rithms for a novel cuproptosis-related gene signature of diagnostic and
immune infiltration in endometriosis. Scientific Reports 13(1): 21603.
24. A Netter, S Noorzadeh, F Duchateau, H Abrao, J Desternes, et al. (2025) Ini-
tial results in the automatic visual recognition of endometriosis lesions by
artificial intelligence during laparoscopy: a proof-of-concept study. Jour -
nal of Minimally Invasive Gynecology 32(12): 1118-1125.
25. S E Korman, G Vissers, M A J Gorris, K Verrijp (2024) Artificial intel -
ligence-based tissue segmentation and cell identification in multi -
plex-stained histological endometriosis sections. Human Reproduction
40(3): 450-460.
26. S Lee, R K Arffman, E K Komsi, O Lindgren, J A Kemppainen, et al. (2024)
AI-algorithm training and validation for identification of endometrial
CD138+ cells in infertility-associated conditions; polycystic ovary syn -
drome (PCOS) and recurrent implantation failure (RIF). Journal of Pathol-
ogy Informatics 15: 100380-100380.
27. N Jiang, H Xie, J Lin, Y Wang, Y Yin, et al. (2022) Diagnosis and Nursing
Intervention of Gynecological Ovarian Endometriosis with Magnetic Res -
onance Imaging under Artificial Intelligence Algorithm. Computational
Intelligence and Neuroscience, p. 1-10.
28. J Avery, A Deslandes, S M Freger, M Leonardi, G Lo, et al. (2023) Non-inva-
sive Diagnostic Imaging for Endometriosis Part 1: A Systematic review of
recent developments in Ultrasound. Combination Imaging and Artificial
Intelligence. Fertility and Sterility 121(2): 164-188.
29. Y Yu, W Hing W, Y Hu, Y Shen, X Xu, et al. (2025) Translation of miRNA
blood-based discovery to molecular testing for clinical diagnosis of endo-
metriosis. medRxiv.
30. M J Iqbal, Z Javed, H Sadia, I A Qureshi, A Irshad, et al. (2021) Clinical appli-
cations of artificial intelligence and machine learning in cancer diagnosis:
looking into the future. Cancer Cell International 21(1): 270-270.
31. P Mishra, A Panda, M Mahapatra, P Dakshinakabat, A Mohanty, et al.
(2024) Application and fallibility of Artificial Intelligence and machine
learning in Diagnostic Pathology. Bangladesh Journal of Medical Science
23(10): S32-S37.
32. J H Harrison, John R Gilbertson, M G Hanna, N H Olson, J N Seheult, et al.
(2021) Introduction to Artificial Intelligence and Machine Learning for
Pathology. Archives of Pathology & Laboratory Medicine 145(10): 1228-
1254.
33. S M Mouazen, S Khan, N S Farag (2025) Machine learning in the early de -
tection of endometriosis: a literature review on symptom clustering and
imaging integration. Precision and Future Medicine 9(3): 117-128.
34. Z Ahmad, S Rahim, M Zubair, J A Ghafar (2021) Artificial intelligence (AI)
in medicine, current applications and future role with special emphasis
on its potential and promise in pathology: present and future impact, ob -
stacles including costs and acceptance among pathologists, practical and
philosophical considerations. A comprehensive review. Diagnostic Pathol-
ogy 16(1): 24-24.
Copyright@ : Raouf Roshdy | Biomed J Sci & Tech Res | BJSTR.MS.ID.010350.
58794
Volume 66- Issue 3
DOI: 10.26717/BJSTR.2026.66.010350
Submission Link: https://biomedres.us/submit-manuscript.php
Assets of Publishing with us
• Global archiving of articles
• Immediate, unrestricted online access
• Rigorous Peer Review Process
• Authors Retain Copyrights
• Unique DOI for all articles
https://biomedres.us/
This work is licensed under Creative
Commons Attribution 4.0 License
ISSN: 2574-1241
DOI: 10.26717/BJSTR.2026.66.010350
Raouf Roshdy . Biomed J Sci & Tech Res